This application is a request for a competitive renewal of our research on the diagnosis and phenomenology of schizophrenia. To our knowledge, this is the largest ongoing study of first-episode schizophrenia in existence. This study is currently following 293 first-episode patients, some of whom have been followed for as long as 15 years. The study emphasizes understanding the phenomenology of schizophrenia by examining the lifetime trajectory of the illness and its long-term outcome. Since the disorder is characterized by a prolonged lifetime course, longitudinal study of a large group of informative patients is one of the most powerful strategies for examining measures that will illuminate its mechanisms or refine the definition of its phenotype. This study examines 4 domains of variables: Symptoms, psychosocial function, brain morphology as measured by morphometric magnetic resonance imaging, and cognition as measured by both standard neuropsychological tests and a group of experimental tests. We have found that, although symptoms stabilize relatively quickly after initial onset in the majority of patients, the other domains tend to worsen throughout the first decade after onset. This suggests that the disorder may have a worse prognosis, despite adequate treatment, than originally anticipated. We also will divide the patients into groups based levels of recovery and determine the predictors of recovery group. In order to understand the long-term outcome of schizophrenia at the clinical, neural, and cognitive levels, it is important that we continue to study this large group of patients longitudinally on into the second decade of the illness so that we can examine the interrelationships between these four domains and determine whether the downward trends persist or stabilize.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH031593-23
Application #
6897230
Study Section
Adult Psychopathology and Disorders of Aging Study Section (APDA)
Program Officer
Heinssen, Robert K
Project Start
1979-01-01
Project End
2009-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
23
Fiscal Year
2005
Total Cost
$848,958
Indirect Cost
Name
University of Iowa
Department
Psychiatry
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Rudd, Danielle S; Axelsen, Michael; Epping, Eric A et al. (2014) A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit model. Am J Med Genet B Neuropsychiatr Genet 165B:619-26
Onwuameze, O E; Nam, K W; Epping, E A et al. (2013) MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med 43:619-31
Andreasen, Nancy C; Liu, Dawei; Ziebell, Steven et al. (2013) Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry 170:609-15
Fusar-Poli, P; Smieskova, R; Kempton, M J et al. (2013) Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev 37:1680-91
Andreasen, N C; Wilcox, M A; Ho, B-C et al. (2012) Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. Mol Psychiatry 17:1093-102
Salinas, Joel; Mills, Elizabeth D; Conrad, Amy L et al. (2012) Sex differences in parietal lobe structure and development. Gend Med 9:44-55
Wassink, Thomas H; Epping, Eric A; Rudd, Danielle et al. (2012) Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 69:885-92
Crespo-Facorro, B; Roiz-Santiáñez, R; Pérez-Iglesias, R et al. (2011) Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. Psychol Med 41:1449-60
Andreasen, Nancy C; Nopoulos, Peg; Magnotta, Vincent et al. (2011) Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 70:672-9
Ho, Beng-Choon; Wassink, Thomas H; Ziebell, Steven et al. (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128:66-75

Showing the most recent 10 out of 216 publications